Pharma Has a Pull-Through Problem—The Answer is Data
PM360
AUGUST 24, 2023
Most market access teams at pharmaceutical and biotech manufacturers have the same problem: evidence of clinical effectiveness isn’t always enough to affect prescribing behavior, often due to—accurate or misperceived—access and affordability concerns. For pharma, it can sometimes feel like a situation beyond their control.
Let's personalize your content